Associations of Gestational Perfluoroalkyl Substances Exposure with Early Childhood BMI z-Scores and Risk of

Yun Liu1, Adaeze C Wosu2, Abby F Fleisch3,4

  • 1Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA.

Insights

Gestational exposure to per- and polyfluoroalkyl substances (PFAS) was linked to slightly higher childhood BMI and obesity risk. These findings suggest a subtle association between maternal PFAS levels and child adiposity.

Area of Science:

  • Environmental Health
  • Pediatric Health
  • Toxicology

Background:

  • Gestational exposure to per- and polyfluoroalkyl substances (PFAS) may influence child adiposity and obesity risk.
  • Previous epidemiological studies on this association have yielded inconsistent results.

Purpose of the Study:

  • To investigate the association between maternal PFAS concentrations during pregnancy and child body mass index (BMI) z-scores.
  • To assess the risk of overweight/obesity in children exposed to PFAS in utero across eight U.S. cohorts.

Main Methods:

  • Utilized data from 1,391 mother-child pairs within the Environmental influences on Child Health Outcomes (ECHO) program.
  • Measured seven PFAS in maternal plasma/serum during pregnancy and child BMI z-scores between ages 2-5 years.
  • Employed linear mixed models, modified Poisson regression, and Bayesian mixture analyses to estimate associations, exploring potential sex modification.

Main Results:

  • Observed subtle positive associations between maternal PFAS levels and child BMI z-scores and overweight/obesity risk.
  • Specific PFAS, such as perfluorohexane sulfonic acid, perfluroundecanoic acid, and N-methyl perfluorooctane sulfonamido acetic acid, showed significant associations.
  • Associations for the PFAS mixture were weaker and less precise; no significant modification by child sex was detected.

Conclusions:

  • Gestational exposure to elevated PFAS levels is associated with slightly increased childhood BMI z-scores and overweight/obesity risk.
  • Further research is warranted to explore the long-term effects of gestational PFAS exposure on adiposity and cardiometabolic health in older children.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
552